The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an incisional hernia.
It was reported that after the underlay implant, the patient experienced adhesions, small bowel friable/oozing blood, bowel loops fistulized, infection, enterotomy, mesh erosion, dilated loops of small bowel, fluid collection, abscess, gram +cocci, rare klebsiella pneumoniae, few streptococcus viridans, abdominal pain, nausea, vomiting, peritonitis, and purulent material.
Post-operative patient treatment included resection of bowel, lysis of adhesions, drainage of abscess, given keentra fresh and frozen plasma [ffp] to reverse anticoagulation, and removal of mesh.
|